Royal Lifescience Corp. Terminates Qualifying Transaction

1780 – 400 Burrard Street Vancouver, British Columbia V6B 3K1

NEWS RELEASE

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Royal Lifescience Corp. Terminates Qualifying Transaction

September 21, 2017 TSX Venture Exchange Trading Symbol: RLS.H

Vancouver, BC – Royal Lifescience Corp. (NEX: “RLS.H”) (the "Company"), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSXV”), announces that its letter of intent with Slave Lake Zinc Corp. announced on July 14, 2017 (the “LOI”) automatically terminated as the parties had not entered into a definitive agreement by August 15, 2017, being the date set out in the LOI. The Company chose not to extend the LOI and to seek to identify a new potential Qualifying Transaction, due to a variety of factors, including the continued weakness in junior equity markets.

The Company will continue to pursue other opportunities with a view to completing a Qualifying Transaction under the CPC policy of the TSXV.

The common shares of the Company are expected to resume trading on the NEX board of the TSXV upon receiving TSXV approval.

About the Company

The Company is designated as a Capital Pool Company by the Exchange. The Company has not commenced commercial operations and has no assets other than cash. The only business of the Company is the identification and evaluation of assets or businesses with a view to completing a "Qualifying Transaction" in accordance with Exchange Policy 2.4 - Capital Pool Companies.

On behalf of the Board of Directors

Minaz Dhanani Chief Executive Officer, Chief Financial Officer, Director

For further information please contact:

Minaz Dhanani Telephone: (604) 783-7361

Neither the TSX Venture Exchange not its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.